- Home
- JAZZ vs AMTM Comparison
JAZZ vs AMTM Comparison
Compare JAZZ & AMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- AMTM
- Stock Information
- Founded
- JAZZ 2003
- AMTM 2020
- Country
- JAZZ Ireland
- AMTM United States
- Employees
- JAZZ N/A
- AMTM N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- AMTM
- Sector
- JAZZ Health Care
- AMTM
- Exchange
- JAZZ Nasdaq
- AMTM NYSE
- Market Cap
- JAZZ 6.1B
- AMTM 5.1B
- IPO Year
- JAZZ 2007
- AMTM N/A
- Fundamental
- Price
- JAZZ $97.78
- AMTM $21.19
- Analyst Decision
- JAZZ Strong Buy
- AMTM Buy
- Analyst Count
- JAZZ 13
- AMTM 5
- Target Price
- JAZZ $181.85
- AMTM $25.80
- AVG Volume (30 Days)
- JAZZ 1.3M
- AMTM 2.0M
- Earning Date
- JAZZ 05-06-2025
- AMTM 05-06-2025
- Dividend Yield
- JAZZ N/A
- AMTM N/A
- EPS Growth
- JAZZ 49.21
- AMTM N/A
- EPS
- JAZZ 7.51
- AMTM 0.10
- Revenue
- JAZZ $4,064,808,000.00
- AMTM $11,261,000,000.00
- Revenue This Year
- JAZZ $7.60
- AMTM $71.01
- Revenue Next Year
- JAZZ $3.47
- AMTM $3.13
- P/E Ratio
- JAZZ $13.00
- AMTM $221.52
- Revenue Growth
- JAZZ 5.76
- AMTM 38.56
- 52 Week Low
- JAZZ $95.49
- AMTM $16.01
- 52 Week High
- JAZZ $148.06
- AMTM $34.50
- Technical
- Relative Strength Index (RSI)
- JAZZ 33.01
- AMTM N/A
- Support Level
- JAZZ $97.50
- AMTM N/A
- Resistance Level
- JAZZ $120.67
- AMTM N/A
- Average True Range (ATR)
- JAZZ 4.33
- AMTM 0.00
- MACD
- JAZZ -0.53
- AMTM 0.00
- Stochastic Oscillator
- JAZZ 1.21
- AMTM 0.00
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About AMTM AMENTUM HOLDINGS INC
Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges.